Bioprocess Automation Market Growth Accelerates: Strategic Forecast Predicts $10.22 Billion by 2029

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Bioprocess Automation Industry Market Size Be by 2025?
In recent years, the bioprocess automation market has experienced rapid expansion. It is projected to increase from $5.67 billion in 2024 to $6.35 billion in 2025, with a compound annual growth rate (CAGR) of 12.0%. The considerable growth during the historic period can be credited to improved efficiency, decreased costs, risk management, a growing need for remote monitoring and control, and decreased reliance on labour.

What's the Long-Term Growth Forecast for the Bioprocess Automation Market Size Through 2029?
In the coming years, the bioprocess automation market is anticipated to experience significant growth. The expected value by 2029 is $10.22 billion, growing at a compound annual growth rate (CAGR) of 12.6%. Factors contributing to this growth in the projected period include improved productivity, regulatory compliance, process optimization, predictive maintenance, and real-time analytics. Key trends to watch in the forecast period are the incorporation of artificial intelligence and machine learning, modular bioprocessing, process control strategies for gene therapy, and data analytics and visualization.

View the full report here:
https://www.thebusinessresearchcompany.com/report/bioprocess-automation-global-market-report

What Are the Key Growth Drivers Fueling the Bioprocess Automation Market Expansion?
Advancements in personalized medicine are predicted to drive the expansion of the bioprocess automation market. Personalized medicine involves the customization of healthcare processes, interventions, and treatments according to each patient's unique traits. This is facilitated by bioprocess automation, which ensures the precision and scalability required to manufacture medications specific to patients. For example, the Personalized Medicine Coalition, a professional membership body in the US, reported in 2022, that the approval of 12 new personalized medicines accounted for roughly 34% of all fresh therapies approved. This represents a significant increase from earlier years. Hence, the rising prevalence of personalized medicines is propelling the growth of the bioprocess automation market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=14058&type=smp

What Are the Key Trends Driving Bioprocess Automation Market Growth?
Leading businesses within the bioprocess automation market are spearheading the development of cutting-edge solutions such as bioreactors, with the goal of streamlining bioprocessing procedures. Defined as an engineered system or apparatus that fosters the ideal, regulated environment for biological and chemical reactions, bioreactors are changing the industry. In the month of April in 2023, for example, the American technology enterprise, Cytiva, renowned for its production of technologies and services designed to expedite the evolution and production of therapeutics, unveiled their X-platform bioreactors. These were created to simplify the operation of single-use upstream bioprocessing tasks. The X-platform bioreactors boast ease of operation, flexibility, and increased efficiency. Initially, they were available in sizes of 50 and 200 litres. These bioreactors have the capacity to optimise process efficacy via ergonomic enhancements, superior production capacity, and rationalised supply chain operations. Besides the production of monoclonal antibodies (mAbs), the X-platform bioreactors can be deployed in the manufacture of cell and gene therapies, as well as viral vectors.

How Is the Bioprocess Automation Market Segmented?
The bioprocess automationmarket covered in this report is segmented -

1) By Component Of Process Control System: Sensors, Actuators, Controllers
2) By Scale Of Operation: Preclinical Operations, Clinical Operations, Commercial Operations
3) By Mode Of Operation: Batch, Fed-Batch, Perfusion
4) By Compatibility With Bioprocessing Systems: Single-Use Systems, Stainless Steel, Other Bioprocessing Systems

Subsegments:
1) By Sensors: Temperature Sensors, Pressure Sensors, Flow Sensors, Level Sensors, PH Sensors, Other Sensors
2) By Actuators: Electric Actuators, Pneumatic Actuators, Hydraulic Actuators, Other Actuators
3) By Controllers: Programmable Logic Controllers (PLC), Distributed Control Systems (DCS), Supervisory Control And Data Acquisition (SCADA), Other Controllers

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=14058&type=smp

Which Companies Are Leading the Charge in Bioprocess Automation Market Innovation?
Major companies operating in the bioprocess automation market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Corporation, Danaher Corporation, Amgen Inc., Merck KGaA, Parker-Hannifin Corporation, CSL Behring LLC, Rockwell Automation Inc., Agilent Technologies Inc., Lonza Group AG, Waters Corporation, Getinge AB, Eppendorf AG, Repligen Corporation, BIONET Research S.A., Flotek Industries Inc., Pierre Guerin SAS, Bioengineering AG, Genedata AG, ILS Automation, INFORS AG, Synthace Limited, Automated Control Concepts Inc., BlueSens gas sensor GmbH, DISTek Integration Inc., Securecell AG, Flownamics Analytical Instruments Inc., Inscripta Inc., PendoTECH Inc., Sartorius Stedim Biotech S.A.

Which Regions Are Leading the Global Bioprocess Automation Market in Revenue?
North America was the largest region in the bioprocess automation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bioprocess automation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=14058

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Speak With Our Expert:
Saumya Sahay,
Americas: +1 310-496-7795,
Asia: +44 7882 955267 & +91 8897263534,
Europe: +44 7882 955267,
Email: saumyas@tbrc.info

The Business Research Company - www.thebusinessresearchcompany.com

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.